Significance of Multiple Lymphocyte-to-C-Reactive Protein Ratios in Predicting Long-Term Major Cardiovascular Adverse Events in Emergency Percutaneous Coronary Intervention Patients with ST-Segment Elevation Myocardial Infarction
Jiangping Ye,Dongxia Xu,Rikang Yuan,Shaoqing Cao,Zhangyu Wang,Yuqin Wang,Chengsi Li,Gangjun Zong
DOI: https://doi.org/10.2147/jir.s462265
IF: 4.5
2024-05-28
Journal of Inflammation Research
Abstract:Jiangping Ye, 1– 3 Dongxia Xu, 1– 3 Rikang Yuan, 1– 3 Shaoqing Cao, 1– 3 Zhangyu Wang, 1– 3 Yuqin Wang, 1– 3 Chengsi Li, 1– 3 Gangjun Zong 1– 3 1 Wuxi Clinical College of Anhui Medical University, Wuxi, Jiangsu, People's Republic of China; 2 Anhui Medical University Fifth Clinical Medical College, Wuxi, Jiangsu, People's Republic of China; 3 Department of Cardiology, The 904th Hospital of Joint Logistic Support Force of PLA, Wuxi, Jiangsu, People's Republic of China Correspondence: Gangjun Zong, Email Aim: The high morbidity and mortality associated with ST-segment elevation myocardial infarction (STEMI) are an urgent concern. This study aimed to investigate the ratio of lymphocyte count to C-reactive protein ratio (LCR) in multiple measurements in the perioperative period, exploring dynamic changes as the best predictor of major adverse cardiovascular events (MACE) in STEMI patients. Methods: We enrolled 205 STEMI patients, conducting blood counts at admission, 24 hours post-percutaneous coronary intervention (PCI), and at discharge. Cox proportional risk models evaluated factors independently associated with STEMI prognosis. The receiver operating characteristic (ROC) curve and the De-Long test determined the best predictor. Kaplan–Meier analysis assessed the prognostic value of LCR for STEMI patients. Statistical differences and correlations between LCR at 24 hours post-PCI and cardiovascular disease risk factors were also analyzed. Results: Gensini score (HR, 1.015; 95% CI, 1.007– 1.022; P < 0.001), total stent length (HR, 1.015; 95% CI, 1.002– 1.029; P =0.025), lipoprotein (a) (HR, 1.001; 95% CI, 1.000– 1.002; P =0.043), LCR at admission (HR, 0.995; 95% CI, 0.989– 1.000; P =0.002), and LCR at 24 hours post-PCI (HR, 0.587; 95% CI, 0.486– 0.708; P < 0.001) were independent risk factors for long-term STEMI prognosis after PCI. LCR at admission (cut-off value, 2.252; 95% CI, 0.040– 0.768; P < 0.001) and LCR at 24 hours post-PCI (cut-off value, 2.252; 95% CI, 0.831– 0.924; P < 0.001) effectively predicted MACEs occurrence, with the latter exhibiting a superior predictive effect ( P < 0.001). Kaplan-Meier analysis revealed that patients with LCR at admission ≤ 50.29 and LCR at 24 hours post-PCI ≤ 2.25 had significantly higher risks of developing MACEs (Log-rank P < 0.0001). Conclusion: LCR at 24 hours post-PCI may be a superior marker for long-term MACE prediction in STEMI patients, serving as the best predictor for distant MACE occurrence. Keywords: lymphocyte, C-reactive protein, major cardiovascular adverse events, percutaneous coronary intervention, ST-segment elevation myocardial infarction Cardiovascular diseases are now a leading global cause of death, significantly impacting human health and quality of life. 1 The genesis and progression of coronary artery disease involve factors such as atherosclerosis from abnormal lipid metabolism and immune dysregulation. 2 In regions with limited medical resources or low-middle income, the incidence and prevalence of coronary artery disease are notably high. 3 ST-segment elevation myocardial infarction (STEMI) progresses swiftly, demanding immediate attention. Its pathogenesis primarily stems from early coronary atherosclerosis and subsequent occlusion due to vulnerable plaque rupture and thrombosis, significantly affecting patient prognosis 4 Emergency percutaneous coronary intervention (PCI) stands out as the preferred reperfusion method for STEMI patients, substantially reducing major adverse cardiovascular events (MACEs). 4,5 Despite timely PCI, some patients still experience MACEs post-surgery, leading to a grim prognosis. 6 Consequently, early identification of patients prone to MACEs and delivering targeted medical care holds paramount importance. Scientific studies have established the pivotal role of the inflammatory immune response in the onset and progression of coronary artery disease, closely influencing the clinical prognosis of patients. 7–9 Lymphocytes, integral to specific immune pathways, signify a reduced count as a cardiovascular event risk. Myocardial infarction-induced lymphocytonia, considered a severe reaction, may correlate with heightened inflammatory mediator release. 10 Serum C-reactive protein (CRP), a classical inflammatory activity indicator, primarily contributes to acute myocardial infarction by activating complement and inducing vascular endothelial dysfunction. CRP predicts cardiovascular events in stable patients with angina pectoris, serving as a marker for atherosclerotic plaqu -Abstract Truncated-
immunology